title: [The incidence of dyslipidemia in a sample of asymptomatic probands established by the means of Lipoprint system].
abstract: Method of lipoprotein determination on polyamideacryl gel Lipoprint enables an exact quantification nonatherogenic and atherogenic plasma lipoproteins. For its use in human medicine this method was recently approved by FDA. According to majority of nonatherogenic, or atherogenic lipoproteins in their spectrum this method can distinguish nonatherogenic type A vs atherogenic type B. After their identification, there is the possibility for exact means of interventions among patients with higher cardiovascular risk. Also in the group of clinically healthy asymptomatic controls with normolipemia it is possible using this method to estimate the certain group of risk of development of premature atherothrombosis.
authors.affiliation: II. interná klinika Lekárskej fakulty UK a UN Bratislava, Slovenská republika. andrej.dukat@faneba.sk
authors.forename: A
authors.initials: A
authors.lastname: Dukát
authors.forename: S
authors.initials: S
authors.lastname: Oravec
authors.forename: M
authors.initials: M
authors.lastname: Wawruch
authors.forename: P
authors.initials: P
authors.lastname: Gavorník
authors.forename: P
authors.initials: P
authors.lastname: Sabaka
mesh_terms: D000328:Adult; D050197:Atherosclerosis / Q000097:blood; D050171:Dyslipidemias / Q000097:blood / Q000175:diagnosis*; D004591:Electrophoresis, Polyacrylamide Gel; D005260:Female; D006801:Humans; D008055:Lipids / Q000097:blood*; D008074:Lipoproteins / Q000097:blood*; D008297:Male; D055815:Young Adult
chemical_list: D008055:Lipids; D008074:Lipoproteins